✦ LIBER ✦

Treatment of FIP1L1/PDGFRA-negative hypereosinophilic syndrome with alemtuzumab, an anti-CD52 antibody

✍ Scribed by Wagner, Lori A.; Speckart, Stephen; Cutter, Bruce; Gleich, Gerald J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term Follow-Up of Patients With Hyp

✍ Strati, Paolo; Cortes, Jorge; Faderl, Stefan; Kantarjian, Hagop; Verstovsek, Srd 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 251 KB

Reconstitution of the T-cell repertoire

✍ Mohammad Reza Rezvany; Mahmood Jeddi Tehrani; Claes Karlsson; Jeanette Lundin; H 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB

Fatal adenovirus infection during alemtu

✍ Nina Cavalli-Björkman; Eva Ösby; Jeanette Lundin; Mats Kalin; Anders Österborg; 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 61 KB

Rebound eosinophilia after treatment of

✍ Kim, Yae-Jean; Prussin, Calman; Martin, Brian; Law, Melissa A.; Haverty, Thomas 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 217 KB

628 Corticosteroid-Sparing Effects of Me

✍ Rosenwasser, L.J.; Schwartz, L.B.; Sheikh, J.; Klion, A.D.; Rothenberg, M.E. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 50 KB

821 Effects of Mepolizumab, an Anti-Inte

✍ Weller, P.F.; Gleich, G.J.; Busse, W.W.; Rothenberg, M.E. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 48 KB